Lorenzoni V, Turchetti G. Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease. Farmeconomia. Health Economics and Therapeutic Pathways. 2014;15(3). https://doi.org/10.7175/fe.v15i3.938